Table 3 Pharmacokinetic properties of compounds 9-23, 30 and 31.

From: Synthesis, cytotoxicity, pharmacokinetic profile, binding with DNA and BSA of new imidazo[1,2-a]pyrazine-benzo[d]imidazol-5-yl hybrids

Comp.

Ar

Exp. Log P

TPSA(Å)

MW

nON

nOHNH

nviolat.

nrot

%ABS

9

1.59

48.02

393

5

0

0

3

92.43

10

1.44

57.26

423

6

0

0

4

89.24

11

0.23

65.10

421

6

0

0

4

86.54

12

1.48

48.02

443

5

0

0

3

92.43

13

1.26

48.02

411

5

0

0

3

92.43

14

1.63

48.02

399

5

0

0

3

92.43

15

1.54

48.02

407

5

0

0

3

92.43

16

View full size image

1.74

48.02

421

5

0

0

4

92.43

17

1.41

65.10

435

6

0

0

4

86.54

18

1.34

48.02

427

5

0

0

3

92.43

19

2.05

48.02

472

5

0

0

3

92.43

20

1.88

57.26

423

6

0

0

4

89.24

21

1.77

48.02

411

5

0

0

3

92.43

22

1.37

48.02

399

5

0

0

3

92.43

23

1.67

48.02

461

5

0

0

4

92.43

30

2.16

65.85

515

7

0

1

4

86.28

31

1.77

65.85

515

7

0

1

4

86.28

  1. TPSA = Total polar surface area, nON = no. of hydrogen acceptors, nOHON = no. of hydrogen donors, nrot = number of rotational bonds, % ABS = percentage of absorbance.